Bemegride (Compound)

Synonyms:bemegride, 64-65-3, 3-Ethyl-3-methylglutarimide, 4-ethyl-4-methylpiperidine-2,6-dione, Methetharimide, Megibal, Megimide, Bemegrid, Eukraton, Mikedimide, Zentraleptin, Agipnon, Megimid, Ahypnon, Antibarbi, Malysol, 2,6-Piperidinedione, 4-ethyl-4-methyl-, 3-Methyl-3-ethylglutarimide, beta-Ethyl-beta-methylglutarimide, Bemigride, Benegrid, NP13, 2,6-Dioxo-4-methyl-4-ethylpiperidine, 4-Ethyl-4-methyl-2,6-dioxopiperidine, 4-Ethyl-4-methyl-2,6-piperidinedione, 4-Methyl-4-ethyl-2,6-dioxopiperidine, Glutarimide, 3-ethyl-3-methyl-, NSC 58187, NSC-58187, 3,3-Methylethylilotarimide, 57DQA39DO2, DTXSID0045250, NP 13, 3-Ethyl-3-methylglutarimide;Bemegrid, .beta.-Ethyl-.beta.-methylglutarimide, .beta.-Methyl-.beta.-ethylglutarimide, CAS-64-65-3, NCGC00016288-01, Bemegridum, Bemegrida, Bemegridum [INN-Latin], Bemegrida [INN-Spanish], beta-Methyl-beta-ethylglutarimide, EINECS 200-588-0, BRN 0116672, UNII-57DQA39DO2, AI3-52526, Bemegride [USP:INN:BAN:JAN], Megibal (TN), Bemegride (JAN/INN), BEMEGRIDE [INN], BEMEGRIDE [JAN], BEMEGRIDE [MI], Prestwick0_000882, Prestwick1_000882, Prestwick2_000882, Prestwick3_000882, 2, 4-ethyl-4-methyl-, BEMEGRIDE [MART.], BEMEGRIDE [WHO-DD], BSPBio_000664, SCHEMBL601065, SPBio_002883, BPBio1_000732, WLN: T6VMVTJ E2 E1, CHEMBL1214192, DTXCID8025250, CHEBI:92269, ORRZGUBHBVWWOP-UHFFFAOYSA-, HMS1570B06, HMS2097B06, HMS3652P09, HMS3714B06, HMS3885L09, BCP18663, HY-B1326, NSC58187, Tox21_110352, MFCD00006673, s4197, AKOS001108082, CCG-220882, CS-4896, DB13740, 2,6-piperidinedione,4-ethyl-4-methyl-, 3-ethyl-5-methyl-piperidine-2,6-dione, 4-ethyl-4-methyl-piperidine-2,6-dione, NCGC00016288-02, NCGC00016288-06, NCGC00179483-01, DS-16419, DB-054709, AB00376458, E0284, FT-0631285, SW197218-3, EN300-18941, D01957, F17053, AB00376458_04, A834846, Q792614, SR-01000872683, SR-01000872683-1, BRD-K14993104-001-03-4, Z99599698

Pubchem:PUBCHEM:2310

Id:4ff3d701-4094-5655-870b-0f0cf44cb4c3

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Bemegride's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Bemegride.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Bemegride.

Results found

Linked to

	Label	Description
	BRD-K14993104-001-05-9 Substance (Entity type)	A Substance
	bemegride (04945aa4-356c-4810-8931-ee5afaab8094) Collection (Entity type)	Metadatata for bemegride
	DCSTRUCT ID 03013 Collection (Entity type)	DrugPage Collection: (DrugCentralID:03013; PubChem_CID:2310, FILE=drugcentral_drug_03013.json)
	Dimenhydrinate in similarity relationship with Bemegride Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bemegride negatively regulates CLGN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bemegride negatively regulates CDKN1A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bemegride positively regulates KRT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bemegride positively regulates XPO7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bemegride negatively regulates ARNT2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bemegride negatively regulates GDF15 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS